endoxan süstelahuse pulber
oÜ baxter estonia - tsüklofosfamiid - süstelahuse pulber - 200mg 1tk; 200mg 10tk
endoxan süstelahuse pulber
oÜ baxter estonia - tsüklofosfamiid - süstelahuse pulber - 500mg 1tk
endoxan kaetud tablett
oÜ baxter estonia - tsüklofosfamiid - kaetud tablett - 50mg 50tk
endoxan süstelahuse pulber
oÜ baxter estonia - tsüklofosfamiid - süstelahuse pulber - 1g 1tk
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubitsiini vesinikkloriid - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastilised ained - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).
plasmalyte infusioonilahus
baxter healthcare limited - elektrolüüdid - infusioonilahus - 500ml 20tk
recombinate süstelahuse pulber ja lahusti
baxter ag - viii hüübimisfaktor - süstelahuse pulber ja lahusti - 500rÜ 10ml 10ml 1tk
hemosol b0 hemodialüüsi-/hemofiltratsioonilahus
baxter holding b.v. - kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+piimhape+naatriumvesinikkarbonaat+naatriumkloriid - hemodialüüsi-/hemofiltratsioonilahus - 5,145g+2,033g+5,4g+3,09g+6,45g 1l 5000ml 2tk
prismasol 4 mmol/l kaalium hemodialüüsi-/hemofiltratsioonilahus
baxter holding b.v. - kaltsiumkloriiddihüdraat+magneesiumkloriidheksahüdraat+glükoos+piimhape+naatriumkloriid+naatriumvesinikkarbonaat+kaaliumkloriid - hemodialüüsi-/hemofiltratsioonilahus - 1,75mmol+0,5mmol+6,1mmol+3mmol+105mmol+32mmol+4mmol 1l 5000ml 2tk
recombinate süstelahuse pulber ja lahusti
baxter ag - viii hüübimisfaktor - süstelahuse pulber ja lahusti - 250rÜ 10ml 10ml 1tk